Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

GeneNews Ltd announces conversion of convertible debentures into common shares


Thursday, 19 Dec 2013 10:10am EST 

GeneNews Ltd:Says the conversion of $2,728,942 outstanding convertible debentures of the company plus accrued interest of $2,046,708 into a total of 10,160,957 common shares of the Company. 

Company Quote

1.32
-0.01 -0.75%
18 Sep 2014